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2Abstract25
The Nairovirus genus of the Bunyaviridae family contains serious human and animal pathogens26
classified within multiple serogroups and species. Of these serogroups, the Crimean-Congo27
hemorrhagic fever virus (CCHFV) serogroup comprises sole members CCHFV and Hazara virus28
(HAZV). CCHFV is an emerging zoonotic virus that causes often-fatal hemorrhagic fever in29
infected humans for which preventative or therapeutic strategies are not available. In contrast30
HAZV is non-pathogenic to humans, and thus represents an excellent model to study aspects of31
CCHFV biology under more accessible biological containment. The three RNA segments that form32
the nairovirus genome are encapsidated by the viral nucleocapsid protein (N) to form33
ribonucleoprotein (RNP) complexes that are substrates for RNA synthesis and packaging into virus34
particles. We used quantitative proteomics to identify cellular interaction partners of CCHFV N,35
and identified robust interactions with cellular chaperones. These interactions were validated using36
immunological methods, and the specific interaction between native CCHFV N and cellular37
chaperones of the HSP70 family was confirmed during live CCHFV infection. Using infectious38
HAZV we showed for the first time that the nairovirus N-HSP70 association was maintained within39
both infected cells and virus particles, where N is assembled as RNPs. Reduction of active HSP7040
levels in cells using small molecule inhibitors significantly reduced HAZV titres, and a model for41
chaperone function in the context of high genetic variability is proposed. These results suggest42
chaperones of the HSP70 family are required for nairovirus replication and thus represent a43
genetically stable cellular therapeutic target for preventing nairovirus-mediated disease.4445
Importance46
Nairoviruses are a group of human and animal viruses that are transmitted by ticks and47
associated with serious or fatal disease. One member is Crimean-Congo hemorrhagic fever virus48
3(CCHFV) that is responsible for fatal human disease and is recognized as an emerging threat within49
Europe in response to climate change. No preventative or therapeutic strategies against nairovirus-50
mediated disease are currently available. Here we show that the N protein of CCHFV and the51
related Hazara virus interact with a cellular protein, HSP70, during both the intracellular and52
extracellular stages of the virus lifecycle. The use of inhibitors that block HSP70 function reduces53
virus titres by up to 1000-fold suggesting this interaction is important within the context of the54
nairovirus life cycle and may represent a potent target for anti-nairoviral therapies, against which55
the virus cannot easily develop resistance.5657
4INTRODUCTION.58
The Bunyaviridae family of tri-segmented negative sense RNA viruses comprises five59
genera namely Orthobunyavirus, Hantavirus, Nairovirus, Phlebovirus and Tospovirus (1). The60
Nairovirus genus contains several serogroups, one of which is the Crimean-Congo hemorrhagic61
fever virus (CCHFV) serogroup with sole members CCHFV and the genetically-distinct Hazara62
virus (HAZV) (2) that are formally grouped under the same species name of CCHFV. CCHFV is a63
Risk Group 4 human pathogen, responsible for a devastating disease for which preventative or64
therapeutic measures do not exist (3). Transmission of CCHFV to humans is often by the bite of65
infected ixodid ticks of the Hyalomma genus (4), and the human case-fatality rate can exceed 60%66
(5). In recent years, incidence of CCHFV-mediated disease has been newly-reported in many67
Mediterranean countries (3), likely as a consequence of the increasingly broad habitat and68
population size of its tick vector, possibly in response to climate change (6). CCHFV is now69
recognized as a potential threat to human health in the densely populated regions of Northern70
Europe (7). In contrast, HAZV has not been associated with serious human disease, and is classified71
as a Risk Group 2 pathogen. HAZV infection of type 1 interferon receptor deficient mice shares72
clinical features of CCHFV-mediated disease in humans and represents an accessible CCHFV73
infection model (8). Taken together, these findings suggest HAZV is a useful surrogate that can be74
used to study the molecular, cellular and disease biology of the highly pathogenic CCHFV, as well75
as other nairoviruses responsible for serious human and animal diseases. Such nairoviruses include76
Erve virus, which causes “thunderclap” headaches in humans (9), and Nairobi sheep disease virus77
that is responsible for haemorrhagic gastroenteritis in livestock such as sheep and goats (10).78
The nairovirus genome comprises three strands of negative sense RNA that are named small79
(S), medium (M) and large (L), reflecting their relative sizes. The S segment encodes the80
nucleocapsid (N) protein, the M segment encodes the envelope glycoproteins Gn and Gc, and the L81
5segment encodes the viral RNA dependent RNA polymerase (RdRp). As with all bunyaviruses, the82
nairovirus genome and anti-genome are encapsidated by multiple copies of the viral N protein to83
form a ribonucleoprotein (RNP) complex. This N-RNA association is thought to be critical to the84
virus replication cycle, and only in the form of the RNP can the CCHFV genome be transcribed and85
replicated (11). The formation of the nairovirus RNP is also dependent on the ability of the N86
protein to interact with itself to form extended oligomers, and details of this interaction have been87
revealed at the atomic level by the CCHFV N protein crystal structure, reported from several groups88
including us (11-13). More recently, the solution of the HAZV N protein crystal structure by others89
and ourselves (14, 15) reveals a high degree of structural similarity with CCHFV N, providing90
further support for the use of HAZV as a model for CCHFV, in particular for functions related to91
their N proteins.92
In addition to these interactions with viral RNP components, bunyavirus N proteins are93
known to interact with multiple cellular proteins, resulting in changes to a range of cellular94
functions such as disruption of host cell signaling pathways (16, 17), cellular mRNA cap binding95
(18, 19), and the recruitment of host cell translation machinery to enhance viral protein expression96
(20, 21). In contrast to bunyaviruses from other genera, less is known about the cellular interacting97
partners specific to the nairovirus N protein. Two interacting cellular proteins have previously been98
identified, namely actin and the large GTPase MxA (22, 23). Although the functional consequences99
of these interactions within the virus replication cycle have not been fully elucidated, these studies100
showed N was capable of interacting with cellular proteins.101
Identification of interactions between host and virus components is important as it holds the102
potential to develop novel disease prevention strategies that focus on either host or viral targets.103
Therapeutic strategies that target host cell components possibly reduce the likelihood of resistance104
developing due to the relatively slow rate of cellular DNA genetic change compared to the more105
6rapid time frame of virus evolution. This is especially pertinent in the case of RNA viruses such as106
CCHFV, which have high mutation rates due to their error prone RNA polymerases (24).107
In order to better understand the interaction between the nairovirus N protein and the host108
cell, we performed a mass spectrometry-based analysis of its co-precipitating cellular proteins.109
Independent validation by immunological means revealed that cellular chaperones were abundant110
interactors, particularly those of the HSP70 family. We showed this interaction was maintained111
throughout both intracellular and extracellular stages of the nairovirus replication cycle, and112
ablation of HSP70 activity using small molecule inhibitors resulted in a 1000-fold reduction of113
infectious HAZV production. This suggests HSP70 family members provide an important role114
within the nairovirus replication cycle, and that inhibition of HSP70 function maybe an important115
therapeutic strategy for currently untreatable viral diseases.116117
7MATERIALS AND METHODS.118
Mammalian cell culture.119
SW13 cells, which are of human adrenal cortex carcinoma cell origin (25), were a kind gift120 from Dr Stuart Dowall and Dr Roger Hewson, of Public Health England (PHE). HEK293T, which are121
of human embryonic kidney cell origin (26), and A549 cells of human alveolar carcinoma cell122
origin (27) were obtained from the Health Protection Agency Culture Collections (HPACC). All cell123 lines were maintained in Dulbecco’s modified Eagle’s medium (DMEM; Sigma Aldrich)124
supplemented with 10% fetal bovine serum (FBS; Invitrogen), 100 IU of penicillin/ml and 100 μg 125
streptomycin/ml and incubated at 37 °C in the presence of 5% CO2. To perform Stable Isotope126
Labeling of Amino acids In Cell culture (SILAC) differential cell labeling studies, HEK293T cells127
were grown in SILAC DMEM supplemented with 10% dialyzed FBS (Dundee Cell Products) and128
100 IU of penicillin/ml and 100 μg streptomycin/ml. Media were named either “light” (R0K0) or 129
“medium” (R6K4) depending on the inclusion of stable isotopes of carbon (13C) or hydrogen (2H) in130
arginine and lysine amino acids. Cells were grown in these media for a minimum period of 2 weeks131
(> 7 cell divisions) prior to transfection, to ensure >95 % cellular protein labeling. For both light132
and medium labeled cells, 4 x 10 cm2 dishes were seeded with 1.25 x 106 HEK293T cells each 24133
hours prior to transfection.134135
Plasmids encoding nairovirus N proteins.136
The CCHFV N protein cDNA sequence from strain Baghdad-12 was cloned into the137
pEGFP-C2 vector (Clontech), to allow mammalian cell expression of the CCHFV N protein fused138
to the C-terminus of EGFP, and the resulting plasmid pEGFP-CCHFV-N was verified by139
sequencing. Expression of native CCHFV N was by cloning the above cDNA into pCAGGS, to140
derive plasmid pCAGGS-CCHFV-N. Expression of both the EGFP-N fusion protein (EGFP-141
8CCHFV-N) and native CCHFV N protein was confirmed by immunofluorescence (IF) and confocal142
microscopy, as well as western blot analysis using either an anti-EGFP antibody (Santa Cruz143
Biotechnology; sc8334), or an anti-CCHFV N antibody generated in house (described below).144145
Bacterial cell expression of nairovirus N proteins and antibody production.146
cDNAs comprising the open reading frames of the N protein of CCHFV strain Baghdad-12147
(accession number; AJ538196.1) and HAZV strain JC280 (accession number; M86624.1)148
optimized for bacterial expression were synthesized by Dundee Cell Products. Expression of149
CCHFV N and HAZV N in E. coli was carried out as described previously (Carter et al, 2012;150
Surtees et al, 2015). Following purification, N purity was confirmed to be >95% by SDS-PAGE,151
and 1 mg N protein in a 1 ml volume was used for antibody production in sheep by Altabiosciences152
Ltd (UK).153154
Transfection.155
HEK293T cells were transfected using Ca3(PO4)2 with 10 μg plasmid DNA encoding 156
EGFP-CCHFV-N or EGFP per 10 cm2 dish. For immunoprecipitation (IP) 4 x 10 cm2 dishes were157
transfected. Plasmid DNA was added to a solution containing sterile filtered 244 mM CaCl2, which158
was added to sterile 2 x HBS (274 mM NaCl, 302 μM Na2HPO4 12H2O, 55 mM HEPES pH 7).159
Solutions of CaCl2, DNA and 2 x HBS were incubated at room temp for 30 mins, prior to addition160
to HEK293T cells. Complete media containing transfection mixes were incubated with HEK293T161
cells overnight, and then replaced with fresh media or cells were harvested. To visualize CCHFV N162
protein using indirect immunofluorescence microscopy, HUH-7 cells were transfected in 60-70 %163
confluent 12-well plates using 0.7 μg pCAGGs-CCHFV-N in 100 μl Opti-MEM with 3 μl 164
lipofectamine 2000 (Invitrogen).165
9166
Nairovirus infections.167
CCHFV (strain Baghdad-12) was used to infect SW13 cells at a multiplicity of infection168
(MOI) of 1.0 under maximum containment conditions at Public Health England, Porton Down. At169
24 h post infection, cells were lysed and lysates were used in IPs using protein G coupled170
Dynabeads, as described below. For HAZV purification, strain JC280 was propagated in SW13171
cells at an MOI 0.001 under Biosafety Level 2 (BSL2) conditions. After 4 days the supernatant172
containing infectious HAZV was harvested, and clarified by centrifugation at 4000 x g at 4 °C for173
20 mins. For HAZV N IPs, sub-confluent SW13 cells grown in 10 cm2 dishes were infected with174
HAZV at MOI 1, and 24 h post infection, cell lysates were used in HAZV N IPs as described175
below.176177
HAZV purification.178
Clarified supernatant from HAZV infected SW13 cells was mixed with 50 % (w/v) PEG179
6000 in TNE buffer (0.01 M Tris pH 7.4, 0.1 M NaCl, 1 mM EDTA), to give a final PEG 6000180
concentration of 10 % (w/v). HAZV was precipitated overnight at 4 °C and then recovered by181
centrifugation at 4000 x g for 30 mins at 4 °C. The resulting pellet was resuspended in 1 ml of TNE182
buffer, then layered on top of a continuous 5 % - 25 % iodixanol gradient in a 13 x 51 mm183
PolyClear centrifuge tube (SETON). After ultracentrifugation at 250,000 x g for 2.5 h at 4 °C184
HAZV particles were isolated using a syringe, mixed gently, and frozen at -80 °C.185186
Plaque assays.187
Plaque assays were performed in 12-well plates using confluent SW13 cells. After adsorption,188
virus was removed and replaced with media diluted 1:1 with 1.6 % (w/v) high viscosity carboxy-189
10
methyl cellulose (Sigma Aldrich). At 6 days, cells were fixed in 20 % (v/v) formalin for 1 h,190
washed 3 times in ddH2O, then stained with crystal violet to visualize plaques.191192
Preparation of cell lysates.193
Cells were harvested from culture dishes by scraping into media, then recovered by194
centrifugation at 4 °C at 4000 x g for 5 mins, washed 3 x in PBS, then resuspended in lysis buffer195
(10 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 0.5% NP40, 1x EDTA-free complete196
protease inhibitor; Roche) for IP, or radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris-197
HCl pH 7.5, 150 mM NaCl, 1 % (v/v) NP40 alternative, 0.5 % (w/v) sodium deoxycholate, 0.1 %198
and 1 x EDTA-free complete protease inhibitor cocktail) for western blot analysis. Cell pellets were199
incubated in RIPA buffer for 30 mins on ice, then lysates were clarified by centrifugation at 13,000200
x g at 4 °C for 10 mins, and the supernatant was either directly used or stored at -20 °C.201202
EGFP-N immunoprecipitations (GFP-trap).203
EGFP and EGFP-CCHFV-N protein IP experiments were performed using a single domain204
anti-GFP antibody conjugated to agarose beads (GFP-trap; Chromotek). IPs with similarly205
conjugated red fluorescent protein (RFP-trap) were performed as non-binding negative controls.206
Cell pellets were incubated for 30 min with 200 µl lysis buffer (10 mM Tris-HCl pH 7.5, 150 mM207
NaCl, 0.5 mM EDTA, 0.5% NP40, 1x EDTA-free protease inhibitor (Roche)). The lysate was208
clarified and diluted five-fold with dilution buffer (10 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5209
mM EDTA, 1x EDTA-free protease inhibitor (Roche)). The GFP/RFP-trap beads were incubated210
with diluted cell lysate for 2 h at 4° C, then centrifuged at 2700 x g for 2 min followed by washing211
twice with wash buffer (10 mM Tris HCl pH 7.5, 250 mM NaCl, 0.5 mM EDTA, 1x EDTA-free212
protease inhibitor (Roche)), then once with wash buffer containing 275 mM NaCl. After213
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centrifugation at 2700 x g pelleted beads were resuspended in 2 x LDS-sample buffer (10 mM214
TrisHCl pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 1 x protease inhibitor cocktail, 1 x LDS and 50215
mM DTT) and heated at 95 °C for 10 mins. Equal volumes of labeled IP samples were mixed and216
analyzed by LC-MS/MS.217218
Native nairovirus N protein immunoprecipitation.219
Recombinant protein G-coupled Dynabeads (Novex) were used to IP native nairovirus N220
proteins from virus-infected and transfected cell lysates using the corresponding anti-N antibodies.221
Dynabead IPs were carried out using a Dynabead protein G IP kit (Life Technologies) according to222
the manufacturer’s instructions. Briefly, 50 μl Dynabeads were bound to CCHFV or HAZV N 223
antibodies, and then incubated with infected or transfected cell lysates for 15 mins at room temp.224
Antigen-antibody complexes were washed in wash buffer and proteins were eluted by heating at 95225
°C for 10 mins in 2 x LDS buffer.226227
Immunofluorescence (IF).228
To visualise various proteins, cells were grown on 19 mm glass coverslips housed in 12 well229
plates. After infection or transfection, cells were washed twice in PBS prior to fixation using either230
4 % formaldehyde (BHD Chemicals) in PBS for 10 mins at room temp, or 4 % paraformaldehyde231
(PFA; BHD chemicals) diluted in PBS for 20 mins at room temp. After fixative removal, cells were232
washed 3 times with PBS, then permeabilised in 0.5 % (v/v) Triton-X 100 in PBS for 12 mins at233
room temp. Permeabilised cells were washed 3 times in PBS, then blocked in 2 % (v/v) FBS in PBS234
for 30 mins. Primary and secondary antibody incubations were performed with antibodies diluted to235
the appropriate concentration in 2 % (v/v) FBS in PBS; after blocking, cells were incubated with 50236
μl of the appropriate primary antibody for 1 h at room temp, then washed 3 x in PBS and incubated 237
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with 50 μl of the appropriate fluorescently labeled secondary antibody for 1 h at room temp. Cells 238
were washed in PBS prior to mounting onto glass slides using ProLong Gold anti-fade reagent (Life239
Technologies) containing DAPI (4',6-diamidino-2-phenylindole). Slides harboring fixed and stained240
cells were analyzed by confocal microscopy using either an inverted laser scanning microscope241
(LSM) 510 META Axiovert 200M, or an upright LSM 510 META Axioplan microscope (Carl242
Zeiss Ltd).243244
MS analysis of EGFP-CCHFV-N immunoprecipitated cell lysates.245
Protein samples generated by GFP-trap IPs were analyzed by SDS-PAGE and separated246
proteins isolated in 10 slices and subjected to in-gel digestion with trypsin. Resulting peptides were247
separated using an Ultimate U3000 nanoflow LC-system (Dionex Corporation) consisting of a248
solvent degasser, micro and nanoflow pumps, flow control module, UV detector and a thermostated249
autosampler. A sample volume of 10 μl (comprising 2 μg) was loaded with a constant flow of 20 250
μl/min onto a PepMap C18 trap column (0.3 mm x 5 mm, Dionex Corporation). After trap 251
enrichment peptides were eluted onto a PepMap C18 nano column (75 μm x 15 cm, Dionex 252
Corporation) with a linear gradient of 5-35% solvent B (90% acetonitrile with 0.1% formic acid)253
over 65 min at a constant flow rate of 300 nl/min. The HPLC system was coupled to a LTQ254
Orbitrap XL (Thermo Fisher Scientific Inc) via a nano ES ion source (Proxeon Biosystems). The255
spray voltage was set to 1.2 kV and the temp of the heated capillary was set to 200oC. Full scan MS256
survey spectra (m/z 335-1800) in profile mode were acquired in the Orbitrap with a resolution of257
60,000 after accumulation of 500,000 ions. The five most intense peptide ions from the Orbitrap258
preview scan were fragmented by collision-induced dissociation (normalized collision energy 35%,259
activation Q 0.250 and activation time 30 ms) in the LTQ after accumulation of 10,000 ions.260
Maximal filling times were 1,000 ms for the full scans and 150 ms for the MS/MS scans. Precursor261
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ion charge state screening was enabled and all unassigned charge states as well as singly charged262
species were rejected. The dynamic exclusion list was restricted to a maximum of 500 entries with a263
maximum retention period of 90 sec and a relative mass window of 10 ppm. The lock mass option264
was enabled for survey scans to improve mass accuracy. The data were acquired using Xcalibur265
software. LC-MS/MS analysis was performed twice on the same protein sample.266267
Peptide quantification.268
Quantification was performed with MaxQuant version 1.0.7.4 (28) based on two-269
dimensional centroid of the isotope clusters within each SILAC pair. The generation of peak list,270
SILAC- and extracted ion current-based quantitation, calculated posterior error probability, false271
discovery rate based on search engine results, peptide to protein group assembly, and data filtration272
and presentation was carried out using MaxQuant. The derived peak list was searched with the273
Mascot search engine (Matrix Science, London, UK) against a concatenated database from274
International Protein Index (IPI) human protein database, and the reversed sequences of all proteins.275
Combined datasets from the two different experiments were deposited in the PRoteomics276
IDEntifications database (PRIDE) using the PRIDE converter tool, and are presented as an277
annotated table (dataset S1).278279
Western blot analysis.280
Proteins were resolved on 12% SDS polyacrylamide gels, transferred to PVDF membranes281
(Immobilon-P, Millipore) or fluorescence compatible PVDF membranes (FL-PVDF) (Immobilon-282
FL Transfer membranes; Millipore) using a Trans-Blot semi-dry cell (Bio-Rad) in Towbin buffer283
(25 mM Tris, 192 mM glycine, 20 % (v/v) methanol) for 1 h at 15 V. Membranes were blocked for284
1 h at room temp in 10 % (w/v) BSA (Sigma Aldrich) in Tris buffered saline (TBS) supplemented285
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with 0.01% Tween-20 (TBS-T) (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1 % Tween-20). FL-286
PVDF membranes were blocked for 1 h at room temp in 50 % (v/v) Odyssey blocking buffer287
(LiCor) in TBS (50 mM Tris-HCl pH 7.5, 150 mM NaCl). Membranes were incubated with primary288
antibody diluted appropriately in 5 % (w/v) BSA in 1 x TSB-T, or in 50 % Odyssey blocking buffer289
in TBS, either for 1 h at room temp or at 4 °C overnight. Primary antibodies used include those290
raised against GFP (Santa Cruz Biotechnology; sc-8334), HSP70/HSC70 (Abcam; Ab6535),291
vimentin (Santa Cruz Biotechnology; sc-966), actin (Sigma Aldrich; A3853), B23.1 (Santa Cruz292
Biotechnology; sc47725), p53 (Cell Signaling; 9282) and GAPDH (Abcam; ab8245). PVDF293
membranes were incubated with an appropriate secondary antibody conjugated to horseradish294
peroxidase (HRP) as described above. FL-PVDF membranes were similarly processed but295
incubated with the appropriate fluorescently labeled secondary antibody. PVDF membranes were296
washed in TBS-T, once in water, and proteins were visualized using enhanced chemiluminescence297
on photographic film. FL-PVDF membranes were washed in TBS, once in water, then imaged using298
a LiCor Odyssey Sa system (LiCor).299300
MS analysis of purified virus; sample preparation and tryptic digestion.301
 Purified virus comprising approximately 11 μg protein was denatured by heating for 10 mins 302
at 95 °C in the presence of DTT. Viral proteins and controls were run approximately 1 cm into a 4-303
12% gel Tris-Bis gradient gel and the proteins were visualized using Coomassie. The entire gel lane304
was excised and cut into smaller pieces, de-stained in 50% acetonitrile/50 mM ammonium305
bicarbonate (pH ~8), reduced for 30 mins at 37 °C with 10 mM dithiothreitol (Sigma Aldrich) in 50306
mM ammonium bicarbonate and alkylated with 55 mM iodoacetamide (Sigma) in 50 mM307
ammonium bicarbonate for 30 mins at room temp. Gel pieces were washed for 15 mins in 50 mM308
ammonium bicarbonate and dehydrated with 100% acetonitrile. Acetonitrile was removed and the309
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gel plugs rehydrated with 0.01 μg/μl proteomic grade trypsin (Sigma Aldrich) in 50 mM 310
ammonium bicarbonate. Digestion was performed overnight at 37 °C. Peptides were extracted from311
the gel plugs using successive 15 min incubations of 3% (v/v) acetonitrile 0.1% (v/v) TFA. Peptide312
extracts were pooled and reduced to dryness using a centrifugal evaporator (Microfuge concentrator313
plus) and re-suspended in 3% (v/v) acetonitrile, 0.1% (v/v) TFA for analysis by mass spectrometry.314315
Mass spectrometry of purified HAZV proteins.316
Peptide mixtures (2 μl) were analyzed by on-line nanoflow liquid chromatography using the 317
nanoACQUITY-nLC system (Waters MS technologies) coupled to an LTQ-Orbitrap Velos318
(Thermo Fisher Scientific) mass spectrometer equipped with a nanospray ion source. The analytical319
column (nanoACQUITY UPLCTM BEH130 C18 15 cm x 75 μm, 1.7 μm capillary column) was 320
maintained at 35 °C and a flow-rate of 300 nl/min. The gradient consisted of 3-40 % acetonitrile in321
0.1 % formic acid for 150 mins then a ramp of 40-85 % acetonitrile in 0.1 % formic acid for 5 mins.322
Full scan MS spectra (m/z range 300- 2000) were acquired by the Orbitrap at a resolution of 30,000.323
The top 20 most intense ions from MS1 scan (full MS) were selected for tandem MS by collision324
induced dissociation and all product spectra were acquired in the LTQ ion trap. Spectral data were325
transformed to .mgf files with Proteowizard (version 3.0) (29) and used for peptide identification326
using the Mascot (version 2.3.02, Matrix Science) search engine. Tandem MS data were searched327
against the HAZV and human predicted proteomes (UniProt Release 2014_02). Mascot search328
parameters were as follows; precursor mass tolerance set to 10 ppm and fragment mass tolerance set329
to 0.8 Da. One missed tryptic cleavage was permitted. Carbamidomethylation (cysteine) was set as330
a fixed modification and oxidation (methionine) set as a variable modification. Mascot search331
results were further processed using Percolator. The false discovery rate was < 1%. Individual ion332
scores > 13 indicated identity or extensive homology (p < 0.05). Approximate, label-free, spectral333
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counting based quantitation of the proteins was determined using the Exponentially Modified334
Protein Abundance Index (emPAI) calculated automatically by the mascot search engine (30).335336
HSP70/HSC70 inhibition.337
Small molecule inhibitors VER155008 and pifithrin-µ (Sigma Aldrich) were both dissolved338
in DMSO (Sigma Aldrich) to make 10 mM stocks, which were further diluted in DMEM339
supplemented with 2 % FBS to the appropriate working concentrations. Assay results were340
compared to those obtained with DMEM supplemented with 2 % FBS containing 0.4 % DMSO.341
A549 cells were seeded in 12 well plates such that cells were 60-70 % confluent when infected, and342
then exposed to the appropriate concentration of PIF and VER. After 1 h, cells were infected with343
HAZV at MOI 1, which was subsequently replaced with fresh media containing appropriate344
concentrations of PIF and VER. At 24 h post-infection cell culture supernatants and whole cell345
lysates were harvested and plaque assayed, or analyzed by western blot.346347
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RESULTS348
Expression of the EGFP-CCHFV N fusion protein.349
To identify cellular proteins that interacted with the nairovirus N protein during the350
replication cycle, an IP based strategy was used to isolate the CCHFV N protein from cells in351
culture followed by mass spectrometry (MS) to identify co-precipitating cellular proteins. CCHFV352
N was initially expressed as an EGFP fusion protein (EGFP-CCHFV-N) in HEK293T cells, chosen353
for three principle reasons; First, their proven ability to support CCHFV replication; second, the354
availability of annotated human proteome databases to facilitate protein identification and function355
assignment; and third, their ability to be efficiently transfected using calcium phosphate. Western356
blot analysis of pEGFP-CCHFV-N-C2 transfected cells identified a protein with the expected 87357
kDa molecular weight predicted for EGFP-CCHFV-N (fig 1A). Direct immunofluorescence (IF)358
confocal analysis of EGFP-CCHFV-N expressing HEK293T cells identified fluorescence in359
perinuclear regions, and also in discrete puncta elsewhere in the cytoplasm (fig 1B), a distribution360
that has been previously described for N during CCHFV infection ((23, 31, 32); also see fig 3C).361
This distribution contrasts to the localization of EGFP alone, expressed from pEGFP-C2, which was362
detected diffusely throughout both the cytoplasm and nucleus (fig 1B).363364
Immunoprecipitation of EGFP-CCHFV-N.365
To identify cellular proteins that only interacted with the N moiety of the EGFP-CCHFV-N366
fusion protein, the precipitated proteins from two different cell populations were compared; one367
expressing EGFP-CCHFV-N and another expressing EGFP alone. Comparison of the resulting data368
sets facilitated the elimination of likely non-specific interaction partners, and guided further369
experimentation to identify proteins specifically binding to CCHFV N.370
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EGFP-CCHFV-N and EGFP were isolated from separate cultures of HEK293T cells by IP371
using a protocol involving a so-called GFP-Trap, which comprises a single chain anti-EGFP372
monoclonal antibody conjugated to agarose. Clarified cell lysates were incubated with the GFP-373
Trap to allow EGFP or EGFP-CCHFV N to bind, along with their associated cellular proteins, then374
bound proteins were examined by SDS-PAGE followed by either Coomassie staining (fig 1C) or375
western blotting using an anti-EGFP and/or anti-CCHFV N antibody (fig 1D). Equal volumes of376
each eluate were mixed together, and combined IP samples were analyzed by mass spectrometry377
(MS).378
To quantify subsequently detected CCHFV N binding proteins, Stable Isotope Labeling by379
Amino acids in Cell culture (SILAC) was used in which the entire cellular proteome was380
metabolically labeled by incorporation of amino acids containing stable isotopes. Cells expressing381
EGFP were grown using ‘medium’ media (containing isotopically labeled arginine and lysine),382
whereas cells expressing EGFP-CCHFV-N were grown in ‘light’ media, without labeled amino383
acids. After mixing IP samples together, distinct masses of precipitated peptides were resolved by384
MS, which revealed the identities and quantities of proteins associated with EGFP-CCHFV-N and385
those associated with EGFP, allowing the relative protein quantities to be represented as a fold386
abundance difference. Cell proteins associated with CCHFV-N would be expected to be highly387
abundant in the EGFP-CCHFV-N precipitated fraction, and in low abundance (or absent) in the388
EGFP precipitated fraction, and so give a correspondingly high abundance ratio.389390
Identification of cellular proteins that interact with the CCHFV N protein.391
In order to provide increased confidence in our data sets, the LC-MS/MS analysis of cellular392
proteins that co-precipitated with EGFP-CCHFV N and EGFP was carried out twice. A total of 192393
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proteins were identified, with 112 common to both analyses; 46 proteins unique to the first analysis394
and 34 unique to the second, and all these are listed in dataset S1.395
Previous studies have suggested the majority of proteins identified by MS in SILAC-based396
GFP-Trap experiments represent proteins that bind non-specifically to EGFP, or the GFP-Trap397
agarose matrix (33, 34). However, the abundance ratio of cellular proteins precipitated with EGFP-398
CCHFV-N compared to EGFP can guide interaction specificity, and previous studies suggest a ratio399
of 5 represents a conservative threshold under which interactions are likely non-specific (34). A400
rational assessment of all identified proteins was performed in order to generate a priority listing of401
putative interactors; the basis for this selection process was a combination of the calculated EGFP-402
CCHFV-N/EGFP abundance ratio (approximately 5 or greater in both analyses) as well as a high403
significance, calculated from the unique peptide count and their corresponding abundance. The404
resulting 6 most likely authentic interacting proteins are listed in fig 2. As described above, the405
CCHFV N protein has previously been shown to bind actin (23), and so this known interaction406
represented an opportunity to assess the success of the GFP-trap and MS/MS identification407
procedure. In good agreement with this work, cytoplasmic actin was identified in both LC-MS/MS408
analyses by 19 and 17 peptides with increased ratios of 6.8 and 16.5 fold, respectively.409410
Independent validation of interacting partners by western blot analysis.411
As described above, a list of cellular proteins that potentially interacted with CCHFV N was412
derived from the MS analysis of IPs using EGFP-CCHFV-N protein. Next, IPs were repeated using413
unlabeled HEK293T cell lysates expressing either EGFP-CCHFV-N or native EGFP, in order to414
verify the putative protein-protein interactions. To determine if cell proteins were precipitated due415
to non-specific interactions with components of the GFP-trap, control IPs were performed using416
both uncoupled agarose beads, and a non-cross reacting RFP-trap, in which antibodies specific for417
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red fluorescent protein (RFP) replaced those specific for GFP. As expected, western blot analysis418
showed the GFP-trap specifically immunoprecipitated EGFP-CCHFV-N and EGFP, whereas the419
RFP-trap and the agarose bead controls did not (fig 2, row 1), thus confirming the effectiveness of420
the GFP-trap for specific precipitation of EGFP and EGFP-CCHFV-N.421
The non-labeled IPs were probed by western blotting using antibodies against selected422
cellular proteins identified by the LC-MS/MS analysis. As described above, cellular actin is known423
to bind CCHFV N protein (23) and so again this known interaction was used as a positive control.424
In agreement with this previous work, western blot analysis of IPs using EGFP-CCHFV-N425
transfected cell lysates revealed actin was abundantly co-immunoprecipitated using the GFP-trap,426
but no actin was detected following IPs using the control RFP-trap or agarose beads alone (fig 2,427
row 2). Other cellular components that exhibited high EGFP-CCHFV-N/EGFP binding ratios and428
were identified by multiple peptides included heat shock protein 70 (HSP70), heat shock cognate 71429
kDa protein (HSC70), vimentin, the tumor suppressor protein p53 and tubulin. For each of these430
cellular proteins, western blot analysis of IPs from EGFP-CCHFV-N expressing cells detected a431
corresponding protein of appropriate molecular weight in both the input material and following IP432
using the GFP-trap, with no or much reduced binding to either the agarose beads alone, or the RFP-433
trap (fig 2 rows 3-6). None of these chosen cellular proteins were identified in similar quantities in434
GFP-trap IPs from cells expressing EGFP alone, indicating the interaction between these cellular435
proteins is EGFP-CCHFV-N specific.436
Both GAPDH and nucleophosmin (B23.1/NPM1) were identified in the LC-MS/MS437
analysis as having low abundance ratios in EGFP-CCHFV-N/EGFP IPs of 4 and 4.5, respectively,438
indicative of likely non-specific interactions (34). In agreement with this, our western blot analysis439
failed to detect the presence of either of these proteins in the IPs from the GFP trap when EGFP-440
CCHFV-N was expressed in cells (fig 2, rows 7-8). In addition, -tubulin also exhibited similarly441
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low ratios of 5.1 and 5.5 in the two LC-MS/MS analyses. Consistent with this, subsequent western442
blot analysis detected -tubulin in the GFP-trap IPs from EGFP-CCHFV-N transfected cells with443
much reduced intensity compared to input cell lysate, suggesting -tubulin may represent a weak or444
transient interacting protein.445446
Validation of the HSP70-N interaction using native CCHFV N.447
The results of the previous section identified cellular proteins that interacted with the EGFP448
CCHFV N fusion protein, including HSP70 and HSC70, which are members of a group of related449
proteins that form the HSP70 family of cellular chaperones (35). Functional interactions between450
heat shock proteins and viral components have recently been documented in other RNA viruses and451
so we further pursued this potential interaction. In order to exclude the possibility that the452
association between HSP70 and N was influenced by the EGFP moiety, native CCHFV N protein453
was expressed both transiently in HEK293T cells, and also during authentic CCHFV infection,454
followed by its precipitation with anti-CCHFV N antibodies made in-house. The specificity of these455
antisera was confirmed by western blot analysis using material harvested from HEK293T cells456
transfected with a CCHFV N expression plasmid, and lysates from CCHFV infected SW13 cells. In457
both cases, the CCHFV N antisera detected a single band of the expected 54 kDa molecular weight458
(fig 3A and 3C; top rows, input). The sub-cellular distribution of native CCHFV N expressed either459
transiently (fig 3B) or in CCHFV infected SW13 cells (fig 3D) was indistinguishable, being460
predominantly perinuclear with additional puncta containing CCHFV N detected in the cytoplasm.461
IP of native CCHFV N from both infected and transfected cells was achieved using462
Dynabeads conjugated to anti-CCHFV N antibodies, after which precipitated proteins were463
analyzed by western blotting. The effectiveness of the IP procedure was confirmed by the abundant464
detection of CCHFV N protein in IP samples (fig 3A and C, top rows, anti-CCHFV N), and the465
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absence of CCHFV N in the lanes corresponding to mock transfected or mock infected cell lysates466
(fig 3A and B; top row, Mock) and unconjugated antibodies incubated with transfected or infected467
cell lysate (fig 3A and B; top row, N unbound). The IP samples were analyzed by western blotting468
using an anti-HSP70 antibody, which revealed the abundant presence of a corresponding 70 kDa469
protein in the anti-CCHFV N IP samples from transiently transfected cells, with no or little protein470
detected in mock transfected cells (fig 3A, boxed lanes). Similarly, anti-HSP70 western blot471
analysis of N protein precipitated from CCHFV infected cells identified a 70 kDa protein, with little472
or no corresponding protein detected in mock-infected cells (fig 3B, boxed lanes). The two cellular473
proteins that were not considered to be CCHFV N interacting partners, GAPDH and B23.1474
(nucleophosmin), were chosen to act as negative controls. Consistent with the proteomics analysis,475
neither of these cellular proteins was detected by western blotting in the anti-CCHFV N IP samples.476
To further examine the interaction between CCHFV N and HSP70/HSC70, indirect IF477
confocal microscopy was performed to determine the cellular localization of endogenous HSP70478
and native CCHFV N transiently expressed in SW13 cells. This analysis showed HSP70/HSC70479
was present at multiple discrete locations throughout the cell, with staining present predominantly480
within the cytoplasm, and often with dense staining in perinuclear regions of both transfected and481
untransfected cells (fig 3E). Co-staining of cells with CCHFV N antisera revealed a predominantly482
perinuclear distribution, and in many instances, the CCHFV N positive puncta co-localized with483
HSP70/HSC70. This suggested a subset of HSP70/HSC70 molecules were associated with CCHFV484
N, although abundant unassociated HSP70/HSC70 was also detected within infected cells, which485
was expected due to its native chaperone roles.486487488489
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HAZV N protein interacts with HSP70 inside infected cells.490
The results of the previous section demonstrated that HSP70 interacted with CCHFV N in491
infected cells. To determine whether this interaction was a common feature of nairovirus N492
proteins, this interaction was also investigated using HAZV N, exploiting the significant logistical493
advantages of working under BSL2, rather than highly restrictive maximum containment conditions494
required for CCHFV.495
SW13 cells were infected with HAZV at MOI 1, and 24 h after infection N protein was496
precipitated using anti-HAZV N antisera under the same conditions used to IP native CCHFV N.497
The ability of the anti-HAZV N antiserum to detect HAZV N was confirmed by western blot498
analysis of cell lysates infected with HAZV, which detected a band of the appropriate molecular499
weight (54 kDa); HAZV N was detected in the input and the anti-HAZV N IP lanes, but was absent500
from the negative control lanes. Next, the co-IP of HSP70/HSC70 with HAZV N was confirmed by501
western blot analysis of IP samples using an anti-HSP70 antibody. This specifically identified a 70502
kDa protein in the input sample, and also in the anti-HAZV N IP sample (fig 4A), thus identifying503
HSP70/HSC70 as an HAZV N interaction partner within infected cells. HSP70/HSC70 was not504
detected, or was detected to a much lesser extent in the IP control lanes from both mock-infected505
cells, or precipitations performed using the unconjugated Dynabead matrix.506
To further evaluate the interaction between N and HSP70 during nairovirus infection,507
indirect IF confocal microscopy was used to determine the subcellular localization of both N and508
HSP70/HSC70 during HAZV infection. As described above for CCHFV N, indirect IF analysis509
showed HSP70/HSC70 partially co-localized with HAZV N in sites that were predominantly510
perinuclear, but staining of HSP70/HSC70 in sites that were free of HAZV N were also evident (fig511
4B). Taken together, this suggests a subset of HSP70/HSC70 molecules are associated with HAZV512
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N during infection, but that free HSP70/HSC70 also exists within infected cells, presumably513
performing its native chaperone function with other client proteins.514515
Identification of host cell proteins packaged within nairovirus particles.516
The experiments described above show the nairovirus N protein interacts with members of517
the HSP70 family within virus-infected cells. One hypothesis that follows from this is that HSP70518
influences the conformation of RNPs during their assembly into progeny virions, which would519
predict the chaperone would be present within assembled and budded virus. To test this, the520
composition of infectious nairovirus particles that are released from cells was investigated. As521
maximum containment protocols are required to grow and purify CCHFV, which is problematical,522
HAZV was used for this analysis instead. HAZV released from cells was purified by523
ultracentrifugation on an iodixanol gradient, resulting in a narrow opalescent band that was524
aspirated (fraction VF1), with the remaining contents of the gradient being collected as 4 sequential525
fractions (F2-F4). All five fractions were analyzed by SDS-PAGE followed by Coomassie (fig 5A)526
or silver staining (fig 5B), which showed a sharp peak in protein abundance in the initially aspirated527
VF1 fraction (protein corresponding to MW of N shown by an asterisk). Higher molecular weight528
proteins were visible, which may correspond to virus components Gn/Gc and L, as well as proteins529
that are likely cellular in origin (fig 5A-B). All fractions were analyzed for the presence of HAZV530
N protein by western blotting using anti-HAZV N antibody (fig 5C, top row), which revealed531
HAZV N protein was almost exclusively found in fraction VF1. Further confirmation that VF1532
contained purified HAZV was that only VF1 was demonstrated to possess infectious virus by533
plaque assay, having a titre of 2 x 105 pfu/ml.534
In order to elucidate the protein composition of purified infectious HAZV, fraction VF1 was535
denatured, separated by SDS-PAGE, and proteins were identified by MS. In addition, the content of536
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fraction F3 was also analyzed by MS to identify proteins present throughout the gradient as537
background contaminants. A total of 264 proteins were identified in VF1, and 82 proteins were538
identified in F3 (dataset S2). Of these 82 proteins, 69 were also identified in VF1. Unless the539
abundances of these proteins were considerably increased within VF1, they were likely dispersed540
throughout the gradient rather than associated within intact HAZV particles, and thus could be541
discounted from further analysis. The peptides identified in fractions VF1 and F3 were ranked in542
accordance with their calculated exponentially modified protein abundance index (emPAI) score.543
As expected, the HAZV N, Gn, Gc and L proteins were detected in VF1, as was actin, previously544
reported to interact with the nairovirus N protein within cells (23). In contrast, analysis of fraction545
F3 showed that actin and all HAZV proteins were either absent or present in negligible quantities.546
The MS analysis of VF1 identified peptides corresponding to several members of the HSP70547
family, and also the HSP90 family. These findings were validated by performing western blot548
analysis on VF1, using antibodies specific for HSP70 and HSP90 family members, which revealed549
abundant presence of proteins corresponding to HSP70/HSC70 and HSP90-alpha and HSP90-beta550
(fig 5C). Trace quantities of these chaperones were also detected in other fractions but in vastly551
reduced abundance compared to VF1, consistent with them being highly enriched in purified virus552
particles.553554
HSP70/HSC70 associated with HAZV N protein in infectious particles.555
The findings of the previous section indicated the abundant presence of cellular chaperones556
of the HSP70 family within purified HAZV particles. Next, we investigated whether these557
chaperones were present within the HAZV particles in association with HAZV N by subjecting558
VF1 to IP using anti-HAZV N antisera. The subsequently precipitated proteins were separated by559
SDS-PAGE, then probed by western blot analysis using anti-HSP70 antibodies, which detected a 70560
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kDa protein consistent with the HSP70/HSC70 targets. The lack of a similar identified protein in561
the control lanes from IPs performed using the unconjugated Dynabead matrix, or from F3562
confirmed the specificity of this interaction (fig 5D). Taken together, these results suggest that563
incorporation of HSP70/HSC70 in infectious HAZV particles was mediated through specific564
interaction with N, most likely in the form of RNPs.565566
Inhibition of HSP70 function using small molecule inhibitors.567
To further examine the importance of HSP70 family chaperones during the nairovirus568
replication cycle, the effects of two previously characterized HSP70 inhibitors, pifithrin-μ (PIF) and 569
VER155008 (VER), on HAZV replication was evaluated. HSP70 and its homologs comprise two570
functionally distinct domains, namely an N-terminal substrate-binding domain (SBD) and a C-571
terminal ATPase domain that allosterically-modulates the activity of the SBD (35). PIF directly572
interacts with the SBD, thus interfering with its ability to bind to client proteins, whereas VER573
targets the ATPase domain, preventing ATP from binding, and consequently inhibiting HSP70574
function by preventing allosteric regulation of the SBD.575
As above, HAZV was utilized for this study, due to the relative ease of handling HAZV576
compared to CCHFV. In order to assess the effects of VER and PIF on HAZV multiplication, we577
first established their cytotoxicity profile in A549 cells by MTT assay (fig 6A) in comparison to a578
base line of 0.4% DMSO, which exceeded the maximal concentration of the solvent used to deliver579
the compounds. Based on previous analyses of HSP70 inhibition by our group (36) inhibitor580
concentrations between 5-20 μM were tested, which resulted in no detectable cellular toxicity, and 581
no reduction in GAPDH expression. We next tested the ability of VER and PIF at 5, 10 and 20 μM 582
concentrations to interfere with virus replication, as determined by plaque assay. As the plaque583
assay measures yield of secreted infectious virus, it would determine how PIF and VER influence584
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all intracellular stages of the virus replication cycle as well as the ability of released virus to infect585
new cells.586
Incubation of HAZV-infected A549 cells with 20 μM VER for 24 h reduced HAZV titres by 587
approximately 1000-fold compared to the DMSO control, whereas over the same 24 h period,588
incubation with 20 μM PIF reduced virus titres by approximately 500-fold (fig 6B). This indicated 589
the production of infectious HAZV virions was greatly diminished in the presence of these590
compounds. These findings establish HSP70/HSC70 as having a critical role in the nairovirus591
replication cycle.592
To better understand this role, we next wanted to gain information on the specific stage of593
the virus replication cycle at which HSP70 and HSC70 acted. To achieve this aim, we examined the594
effect of PIF and VER on the quantity of HAZV N protein that was expressed during infection (fig595
6C and D). This analysis revealed a gradual decrease in HAZV N expression as the concentration of596
VER increased, such that N expression was approximately 70% that of the DMSO control at a sub-597
toxic VER concentration of 20 μM. When cells were incubated with PIF, the use of the same sub-598
toxic 20 μM concentration resulted in a greater decrease in N expression levels, to approximately 599
25% of DMSO controls (fig 6C and D). These findings suggest that HSP70/HSC70 is required600
during the HAZV replication cycle at a stage prior to protein synthesis, such as genome replication601
or gene expression rather than at a later stage such as virus assembly and egress.602603
28
DISCUSSION.604
RNA viruses have limited coding capacity and to compensate for this many of their proteins605
exhibit remarkable structural economy often possessing multiple functions. An additional strategy606
viruses have adopted to increase their functional repertoire is to subvert the function of host cell607
components. Based on the hypothesis that nairovirus N proteins must interact with specific host cell608
proteins to complete the infectious cycle, we aimed to determine the identity of these associating609
cellular factors. To achieve this aim, we utilized both quantitative proteomics and conventional IP610
protocols to elucidate the identity of interacting cellular proteins that co-precipitate with CCHFV611
and HAZV N proteins during both intracellular and extracellular phases of their replication cycles.612
Our results indicated that many interacting proteins of CCHFV N were components of the613
cellular cytoskeleton, including actin, tubulin and vimentin. Relevant to this current study, CCHFV614
N has previously been shown to interact with actin, and this provides further confidence in our615
findings. The role of these cytoskeletal components in the CCHFV replication cycle is unclear,616
although strong possibilities must include the trafficking of viral components from the site of virus617
entry or uncoating, to virus factories where synthesis of viral components for later assembly of618
progeny virions takes place. However, the most abundant interacting partners of CCHFV N were619
members of the HSP70 family of ATP-dependent cellular chaperones, which in association with620
dnaJ cofactor adapter proteins perform roles that relate to correct folding and transport of newly621
synthesized and mis-folded proteins, as well as the assembly of multi-component complexes (37).622
We also showed that the N protein of the closely related HAZV also associates with HSP70 family623
members, not only within infected cells, but also in secreted infectious virus particles. Due to the624
extremely close structural similarity between these two N proteins (14), we suggest that the N-625
HSP70 interactions we have observed in both HAZV and CCHFV are similarly related. This626
reasoning led us to test the functional role of HSP70 family members throughout the HAZV627
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replication cycle, and to propose that the findings of this analysis would also apply to the infectious628
cycle of CCHFV.629
Growing evidence from the literature indicates that members of the HSP70 family of630
chaperones functionally interact with proteins belonging to viruses classified in many different631
groups spanning DNA and RNA viruses infecting a bewildering array of unicellular and632
multicellular organisms. For negative stranded RNA viruses (of which nairoviruses are examples)633
the most commonly reported role of HSP70/HSC70 is its interaction with components of the viral634
RNA synthesis machinery, which influences both transcription and replication of viral RNA.635
Examples include HSP70/HSC70 interactions with the N proteins of rabies virus (38), measles virus636
(39) and Hantaan virus (40) the polymerase subunits PB1 and PB2 from influenza A virus (41, 42),637
and components of the HRSV polymerase complex (36, 43-45). Interestingly, the role of638
HSP70/HSC70 in RNA synthetic processes has been shown to be sometimes stimulatory and639
sometimes inhibitory. In the case of HRSV, depletion or inhibition of the associated heat shock640
proteins was found to have an inhibitory affect on RNA synthesis, suggesting HSP70/HSC70 had a641
positive role in the viral replication cycle, and it was postulated that the chaperone enhanced642
polymerase activity by facilitating its correct folding. In contrast, the role of HSP70 in influenza A643
virus (FLUAV) RNA synthesis is apparently more complex, with initial reports suggesting it644
disrupts polymerase-RNA binding, leading to reduced transcription and replication (41). However645
more recent conflicting reports indicate that FLUAV RNA synthesis is stimulated by physiological646
concentrations of HSP70, but inhibited when HSP70 is over expressed through heat shock647
stimulation or transient expression (42).648
In order to assess whether the HSP70/HSC70 interaction was beneficial or detrimental to the649
nairovirus replication cycle, we tested the impact on HAZV replication of modulating650
HSP70/HSC70 function using the previously described HSP70/HSC70 inhibitors PIF and VER651
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(46). These chaperones, along with their cofactors, are emerging as potent and promising anti-viral652
targets (47). PIF and VER were carefully titrated to ensure that the concentrations used were non-653
cytotoxic as measured by MTT assay and expression of cellular GAPDH. For both inhibitors, the654
yield in secreted infectious virus was dramatically reduced by at least 90%, when used at a655
concentration of 20 μM, which was conservatively chosen to rule out any off target effects. Taken 656
together, these consistent findings suggest that HSP70/HSC70 plays an important beneficial role in657
the HAZV replication cycle that is independent from the native role of HSP70/HSC70 in host cell658
processes.659
An important question that we wish to now ask is at what stage of the nairovirus replication660
cycle is HSP70/HSC70 acting, such that it is essential for virus production? The finding that PIF661
and VER both cause a dramatic reduction in the accumulation of N protein at non-toxic662
concentrations suggest that HSC70/HSP70 likely influences one or more early stages of the663
replication cycle, prior to or including protein production, such as virus entry, uncoating, RNA664
synthesis or protein synthesis. The packaging of these chaperones in association with RNPs within a665
secreted, infectious particle is also consistent with an early role in the viral replication cycle, when666
RNPs are released from the virion into the cytosol. Possible roles include facilitating RNP667
conformational changes that may be required for dissociation of RNPs from the glycoprotein668
endodomains, or decondensation of RNPs in preparation for primary transcription. Interestingly, a669
role for HSP70/HSC70 in early RNP functions has been proposed for canine distemper virus (48),670
another negative stranded RNA virus. These authors suggested that HSP70/HSC70 could be671
required for remodeling of the RNP template, perhaps from a condensed to a more relaxed672
conformation, and that this switch may be needed for gene expression. However, HSP70 family673
members and their associated dnaJ cofactors may play important pro-viral roles in more than one674
stage of the nairovirus lifecycle. Dependence on the HSP70/dnaJ chaperone network at all stages of675
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the dengue virus 2 (DENV-2) replication cycle was recently comprehensively dissected, assigning676
defined roles to multiple HSP70 isoforms and dnaJ protein combinations (47). This work revealed677
an important role for cytosolic cofactor dnaJ A2 during DENV RNA replication, and interestingly678
this factor was detected in the MS analysis of precipitated CCHFV N, also consistent with a role in679
nairovirus RNA replication. It is also noteworthy that the dnaJ B11 cofactor found to be required680
for DENV assembly was the sole dnaJ cofactor found in HAZV particles, also suggestive that681
members of the HSP70/dnaJ network represent pro-viral cell factors that are required across diverse682
virus families.683
In regards to the role of the N-HSP70 interaction, it has previously been shown that heat684
shock proteins rescue the ability of mutant proteins to adopt a native conformation (49). In the685
context of RNA viruses, this ability may be particularly beneficial in order to mitigate the686
consequences of their high genome mutation rates, which could otherwise result in the generation of687
pools of misfolded viral proteins. It has been suggested that large multi-subunit complexes that688
depend on the precise geometry of interacting components may be particularly vulnerable to protein689
misfolding, as a single misfolded subunit may render the entire complex defective (50). In the case690
of the negative stranded RNA viruses such as nairoviruses, they possess RNP complexes built from691
multiple copies of N protein in association with the RNA genome, as well as an associated692
polymerase. The nairovirus L segment is over 12,000 nucleotides long, and is likely encapsidated693
by over 1000 N protein monomers that enwrap the long L segment RNA. It is feasible that the694
nairoviruses may have developed a strategy involving cellular chaperones to protect this significant695
metabolic investment in the face of frequent polymerase error. A better understanding of critical696
virus-host cell interactions such as the N-HSP70 interaction may aid in the design of effective697
control strategies for pathogenic viruses within the Nairovirus genus, as well as other related698
viruses. This may be particularly promising in the case of heat shock proteins, as many699
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corresponding inhibitory compounds are well characterized, and viruses appear unable to develop700
resistance (51).701702
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Figure legends.873
Figure 1. Expression and immunoprecipitation of EGFP-CCHFV-N in HEK293T cells. A).874
HEK293T cells were transfected with a plasmid designed to express an EGFP-CCHFV-N fusion875
protein, which was detected by western blot analysis of cell lysates using an anti-CCHFV N876
antibody. B) HEK293T cells were transfected with plasmids expressing EGFP or EGFP-CCHFV-877
N, and their subcellular localization was determined using confocal microscopy, with the nucleus878
stained blue using DAPI, and EGFP and EGFP-CCHFV-N detected as green. Following GFP-trap879
mediated IP from EGFP and EGFP-CCHFV-N expressing cells, proteins were resolved by SDS-880
PAGE, and visualized by either C) Coomassie staining, or D) by western blotting with an anti-GFP881
antibody. Unfilled arrowheads denote EGFP-CCHFV-N.882883
Figure 2. Validation of selected CCHFV N protein cellular interaction partners. HEK293T cells884
were transfected with EGFP-CCHFV-N and EGFP, and 24 h later cell lysate components were885
immunoprecipitated with either GFP-trap, RFP-trap or unconjugated agarose beads. Resulting IPs886
were separated by PAGE then western blotted to probe for the presence of the selected cellular887
proteins listed using specific antibodies. The abundance ratio of these proteins determined by the888
two SILAC LC-MS/MS analyses are indicated, and a complete list of all interaction partners is889
provided as an annotated table in supplementary dataset S1.890891
Figure 3. Interaction between cellular HSP70 and native CCHFV N expressed transiently or892
during CCHFV infection. A) Anti-CCHFV N antisera was used to IP native CCHFV N expressed893
in HEK293T cells, and isolated proteins were analyzed by western blotting using the antibodies894
shown. B) The subcellular localization of native CCHFV N in HUH-7 cells was investigated using895
indirect immune fluorescence microscopy using anti-CCHFV N antisera, shown as green. Nuclei896
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are stained with DAPI, shown as blue. C) Anti-CCHFV N antisera was used to IP native CCHFV N897
from CCHFV infected SW13 cells, and isolated proteins were analyzed by western blotting using898
the antibodies shown. D) The subcellular localization of native CCHFV N in CCHFV infected899
SW13 cells was investigated by indirect immune fluorescence microscopy using anti-CCHFV N900
antisera, shown as green. The nuclei are stained with DAPI, shown as blue. E) Indirect confocal901
immunofluorescence analysis of SW13 cells transiently expressing native CCHFV-N protein902
expressed from a plasmid cDNA. Cells were co-stained using antibodies specific for CCHFV N903
(green) and anti-HSP70 (red), with donkey and chicken secondary antibodies, respectively, as well904
as DAPI (blue).905906
Figure 4. Analysis of the interaction between HAZV N and HSP70 in cells. A) HAZV N was907
immunoprecipitated from HAZV infected cells using anti-N antisera, and then western blotted using908
the antibodies shown. B) Indirect confocal immunofluorescence analysis of SW13 cells infected909
with HAZV revealed HAZV N (green) localized in discrete cytoplasmic puncta, similar to CCHFV910
N. HSP70 (red) was present in both the cytoplasm and nucleus, and also co-localised with HAZV N911
in some cytoplasmic puncta. Nuclei are stained with DAPI, shown as blue.912913914
Figure 5. SDS-PAGE analysis of purified HAZV harvested from SW13 cell supernatant, and915
western blot confirmation of the presence of HSP70 and HSP90 family members. Secreted HAZV916
particles harvested from infected SW13 cell supernatants were purified by PEG precipitation917
followed by centrifugation through an iodixanol gradient. HAZV particles were isolated (lane VF1),918
and the remaining 4 fractions of 1 ml were collected from the top of the gradient (F2) to the bottom919
of the gradient (F5). Fractions were analyzed by SDS-PAGE, and either A) Coomassie stained or B)920
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silver stained. C) Fraction VF1 was subjected to western blot analysis using both anti-HAZV N921
antisera, and antibodies targeting the listed cellular proteins, including HSP70. D) HAZV N was922
immunoprecipitated from purified infectious HAZV, and then subjected to western blot analysis923
using anti-HAZV N and anti-HSP70 antibodies.924925
Figure 6. The effect of HSP70/HSC70 inhibitors VER and PIF on HAZV replication. A)926
Cytotoxicity of VER and PIF in SW13 cells was assessed by MTT assay after 24 hrs incubation of927
SW13 cells with VER and PIF at several different concentrations, in the absence of HAZV.928
Cytotoxicity levels are presented relative to 0.4% DMSO. B) The effect on HAZV replication of929
treating A549 cells with VER and PIF was determined by plaque assay, which revealed a reduction930
in HAZV titres at sub-cytotoxic PIF and VER concentrations. The statistical significance of931
decreased virus multiplication using PIF and VER in relation to DMSO-only controls was assessed932
using a paired students T test, and significance shown with an asterisk (*). C) Western blot analysis933
of HAZV N protein and GAPDH levels within infected cells following PIF and VER treatment at934
sub-cytotoxic concentrations. D) HAZV N protein levels quantified from western blots performed935
from three experiments.936937938






